Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$67,269,967
-$696,727 QoQ
Shares Held
1,167,476
+4.2% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#135
of 2,506 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $1,229,733,122 across 9 Drug Manufacturers - General names. BMY ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
244,861 | $293,693,653 | |
| 2 | JNJ |
Johnson & Johnson
|
1,050,526 | $266,802,088 | |
| 3 | ABBV |
AbbVie Inc.
|
907,363 | $228,328,825 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,124,149 | $144,453,146 | |
| 5 | AMGN |
Amgen Inc
|
238,092 | $86,217,875 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
1,167,476 | $67,269,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
528,600 | $66,783,324 | |
| 8 | PFE |
Pfizer Inc
|
2,154,713 | $51,885,489 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,269,967 | 1,167,476 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $67,966,694 | 1,120,638 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $57,668,170 | 1,069,117 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $44,660,320 | 990,251 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $45,195,704 | 976,360 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $78,775,598 | 1,291,615 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $88,325,340 | 1,561,622 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $40,261,791 | 778,156 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,694,533 | 763,172 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,716,644 | 769,254 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $39,462,418 | 769,098 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,783,339 | 237,480 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,802,790 | 200,200 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,132,397 | 261,613 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,611,306 | 258,670 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,045,011 | 267,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $65,463,860 | 850,180 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $28,888,477 | 395,570 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $24,663,789 | 395,570 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $23,405,876 | 395,570 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $26,431,987 | 395,570 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $38,309,241 | 606,831 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $66,544,605 | 1,103,742 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||